A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

The Prevalence of Out-patients With Rheumatoid Arthritis Fulfilling the Indication for Anti-tumor Necrosis Factor(TNFa) Therapy in General Hospital Setting in Korea: a Multi-center, Non-interventional, Observational Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01294722

Enrollment

1700

Registered

2011-02-11

Start date

2011-12-31

Completion date

2012-08-31

Last updated

2013-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

Rheumatoid Arthritis, anti-TNF α

Brief summary

This is an observational study to estimate the proportion of patients diagnosed with RA visiting a medical internist in a general hospital in Korea who are candidates for anti-TNF α therapy.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosed with RA * Visiting a medical internist in a study site during the study period on out patient basis * Able to give written informed consent voluntarily

Exclusion criteria

None

Design outcomes

Primary

Measure	Time frame
Number of anti-TNF α agent candidates fulfilling the reimbursement guideline of Korea government in total out-patients with RA	Baseline
Number of anti-TNF α agent candidates based on the clinical judgement in total out- patients with RA	Baseline

Countries

South Korea

Outcome results